Pulse Co-oximeter

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
16-11-2017

から入手可能:

Masimo Australia Pty Ltd

クラス:

Class IIb

製:

Masimo Corporation 52 Discovery, Irvine, CA, 92618 United States Of America

治療領域:

46201 - Pulse Co-oximeter

適応症:

The device is indicated for the continuous non-invasive monitoring of functional oxygen saturation of arterial haemoglobin (SpO2), pulse rate, carboxyhemoglobin saturation, methemoglobin saturation, total haemoglobin concentration, and/or respiratory rate.; and is indicated for use with adult, paediatric, and neonatal patients during both no motion and motion conditions, and for patients who are well or poorly perfused in hospitals, hospital-type facilities, and mobile environments. The device has an additional mode to provide clinicians with a guided tool to help screen newborns for Critical Congenital Heart Disease (CCHD) per the established CCHD Screening protocol.

認証ステータス:

A

承認日:

2008-12-03

この製品に関連するアラートを検索

ドキュメントの履歴を表示する